Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8151692
[patent_doc_number] => 08168169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Methods and compositions for the treatment of medical disorders'
[patent_app_type] => utility
[patent_app_number] => 11/891138
[patent_app_country] => US
[patent_app_date] => 2007-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 14620
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11891138
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/891138 | Methods and compositions for the treatment of medical disorders | Aug 7, 2007 | Issued |
Array
(
[id] => 5423181
[patent_doc_number] => 20090149637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'Human antibodies derived from immunized xenomice'
[patent_app_type] => utility
[patent_app_number] => 11/891292
[patent_app_country] => US
[patent_app_date] => 2007-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12644
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149637.pdf
[firstpage_image] =>[orig_patent_app_number] => 11891292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/891292 | Human antibodies derived from immunized xenomice | Aug 7, 2007 | Abandoned |
Array
(
[id] => 6266439
[patent_doc_number] => 20100298226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA'
[patent_app_type] => utility
[patent_app_number] => 12/309856
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16792
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20100298226.pdf
[firstpage_image] =>[orig_patent_app_number] => 12309856
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/309856 | POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA | Jul 30, 2007 | Abandoned |
Array
(
[id] => 5290466
[patent_doc_number] => 20090023196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Stocks of replication-deficient adenovirus'
[patent_app_type] => utility
[patent_app_number] => 11/879421
[patent_app_country] => US
[patent_app_date] => 2007-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 16433
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11879421
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/879421 | Stocks of replication-deficient adenovirus | Jul 15, 2007 | Abandoned |
Array
(
[id] => 6513794
[patent_doc_number] => 20100011454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'HUMAN ARTIFICIAL CHROMOSOME (HAC) VECTOR AND HUMAN CELL MEDICINE COMPRISING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/307879
[patent_app_country] => US
[patent_app_date] => 2007-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 91
[patent_no_of_words] => 75557
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20100011454.pdf
[firstpage_image] =>[orig_patent_app_number] => 12307879
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307879 | Human artificial chromosome (HAC) vector and human cell medicine comprising same | Jul 5, 2007 | Issued |
Array
(
[id] => 4727212
[patent_doc_number] => 20080206754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Method for producing monoclonal antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/819917
[patent_app_country] => US
[patent_app_date] => 2007-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4384
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206754.pdf
[firstpage_image] =>[orig_patent_app_number] => 11819917
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/819917 | Method for producing monoclonal antibodies | Jun 28, 2007 | Abandoned |
Array
(
[id] => 4872708
[patent_doc_number] => 20080199442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors'
[patent_app_type] => utility
[patent_app_number] => 11/821271
[patent_app_country] => US
[patent_app_date] => 2007-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12831
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199442.pdf
[firstpage_image] =>[orig_patent_app_number] => 11821271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/821271 | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors | Jun 21, 2007 | Abandoned |
Array
(
[id] => 162989
[patent_doc_number] => 07671250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'Method of acquiring immunological tolerance'
[patent_app_type] => utility
[patent_app_number] => 11/812762
[patent_app_country] => US
[patent_app_date] => 2007-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4736
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/671/07671250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11812762
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/812762 | Method of acquiring immunological tolerance | Jun 20, 2007 | Issued |
Array
(
[id] => 4932431
[patent_doc_number] => 20080003206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'ABCB5 positive mesenchymal stem cells as immunomodulators'
[patent_app_type] => utility
[patent_app_number] => 11/809790
[patent_app_country] => US
[patent_app_date] => 2007-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15532
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003206.pdf
[firstpage_image] =>[orig_patent_app_number] => 11809790
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/809790 | ABCB5 positive mesenchymal stem cells as immunomodulators | May 30, 2007 | Issued |
Array
(
[id] => 130149
[patent_doc_number] => 07699801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Advanced genetic vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/752173
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17320
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/699/07699801.pdf
[firstpage_image] =>[orig_patent_app_number] => 11752173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/752173 | Advanced genetic vaccines | May 21, 2007 | Issued |
Array
(
[id] => 5373665
[patent_doc_number] => 20090311226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING ESOPHAGEAL DYSPLASIA'
[patent_app_type] => utility
[patent_app_number] => 12/300685
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9592
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311226.pdf
[firstpage_image] =>[orig_patent_app_number] => 12300685
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/300685 | COMPOSITION AND METHOD FOR TREATING ESOPHAGEAL DYSPLASIA | May 21, 2007 | Abandoned |
Array
(
[id] => 5045601
[patent_doc_number] => 20070264274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Veto cells effective in preventing graft rejection and devoid of graft versus host potential'
[patent_app_type] => utility
[patent_app_number] => 11/802182
[patent_app_country] => US
[patent_app_date] => 2007-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13489
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264274.pdf
[firstpage_image] =>[orig_patent_app_number] => 11802182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/802182 | Veto cells effective in preventing graft rejection and devoid of graft versus host potential | May 20, 2007 | Abandoned |
Array
(
[id] => 5045609
[patent_doc_number] => 20070264282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'HERPES VIRUS STRAINS FOR GENE THERAPY'
[patent_app_type] => utility
[patent_app_number] => 11/738807
[patent_app_country] => US
[patent_app_date] => 2007-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5681
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264282.pdf
[firstpage_image] =>[orig_patent_app_number] => 11738807
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/738807 | Herpes virus strains for gene therapy | Apr 22, 2007 | Issued |
Array
(
[id] => 5166095
[patent_doc_number] => 20070287682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-13
[patent_title] => 'Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor'
[patent_app_type] => utility
[patent_app_number] => 11/788728
[patent_app_country] => US
[patent_app_date] => 2007-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8268
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20070287682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11788728
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/788728 | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor | Apr 19, 2007 | Abandoned |
Array
(
[id] => 4909180
[patent_doc_number] => 20080019946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'Integration-type low-dose radiation-inducible vector'
[patent_app_type] => utility
[patent_app_number] => 11/788256
[patent_app_country] => US
[patent_app_date] => 2007-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12067
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20080019946.pdf
[firstpage_image] =>[orig_patent_app_number] => 11788256
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/788256 | Integration-type low-dose radiation-inducible vector | Apr 18, 2007 | Abandoned |
Array
(
[id] => 5459941
[patent_doc_number] => 20090260093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'TRANSGENIC ANIMALS EXPRESSING CHIMERIC ANTIBODIES FOR USE IN PREPARING HUMAN ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/295557
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16408
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20090260093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12295557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/295557 | Transgenic animals expressing chimeric antibodies for use in preparing human antibodies | Mar 29, 2007 | Issued |
Array
(
[id] => 4938856
[patent_doc_number] => 20080076175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Somatic transgene immunization and related methods'
[patent_app_type] => utility
[patent_app_number] => 11/713477
[patent_app_country] => US
[patent_app_date] => 2007-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18711
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076175.pdf
[firstpage_image] =>[orig_patent_app_number] => 11713477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/713477 | Somatic transgene immunization and related methods | Feb 28, 2007 | Abandoned |
Array
(
[id] => 5027963
[patent_doc_number] => 20070269410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Chimeric adenoviral vectors'
[patent_app_type] => utility
[patent_app_number] => 11/712794
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15660
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11712794
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/712794 | Chimeric adenoviral vectors | Feb 27, 2007 | Issued |
Array
(
[id] => 4921521
[patent_doc_number] => 20080069836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'METHOD OF USING ADENOVIRAL VECTORS WITH INCREASED IMMUNOGENICITY IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 11/678947
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14736
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20080069836.pdf
[firstpage_image] =>[orig_patent_app_number] => 11678947
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/678947 | METHOD OF USING ADENOVIRAL VECTORS WITH INCREASED IMMUNOGENICITY IN VIVO | Feb 25, 2007 | Abandoned |
Array
(
[id] => 4478197
[patent_doc_number] => 07906628
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Targeting proteins to deliver therapeutic or diagnostic reagents'
[patent_app_type] => utility
[patent_app_number] => 11/672799
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27083
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906628.pdf
[firstpage_image] =>[orig_patent_app_number] => 11672799
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/672799 | Targeting proteins to deliver therapeutic or diagnostic reagents | Feb 7, 2007 | Issued |